HUP9800731A3 - Stimulation of meiosis - Google Patents

Stimulation of meiosis

Info

Publication number
HUP9800731A3
HUP9800731A3 HU9800731A HUP9800731A HUP9800731A3 HU P9800731 A3 HUP9800731 A3 HU P9800731A3 HU 9800731 A HU9800731 A HU 9800731A HU P9800731 A HUP9800731 A HU P9800731A HU P9800731 A3 HUP9800731 A3 HU P9800731A3
Authority
HU
Hungary
Prior art keywords
meiosis
stimulation
Prior art date
Application number
HU9800731A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of HUP9800731A2 publication Critical patent/HUP9800731A2/hu
Publication of HUP9800731A3 publication Critical patent/HUP9800731A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/061—Sperm cells, spermatogonia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU9800731A 1995-03-06 1996-03-06 Stimulation of meiosis HUP9800731A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK23295 1995-03-06
DK30995 1995-03-24

Publications (2)

Publication Number Publication Date
HUP9800731A2 HUP9800731A2 (hu) 1998-07-28
HUP9800731A3 true HUP9800731A3 (en) 2000-03-28

Family

ID=26063579

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800731A HUP9800731A3 (en) 1995-03-06 1996-03-06 Stimulation of meiosis

Country Status (13)

Country Link
US (1) US5830757A (hu)
EP (1) EP0813595A1 (hu)
JP (1) JPH11501806A (hu)
KR (1) KR19980702624A (hu)
AU (1) AU717180B2 (hu)
BR (1) BR9607673A (hu)
CA (1) CA2214126A1 (hu)
CZ (1) CZ279797A3 (hu)
HU (1) HUP9800731A3 (hu)
NO (1) NO974089D0 (hu)
PL (1) PL322106A1 (hu)
RU (1) RU2188006C2 (hu)
WO (1) WO1996027658A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130249A0 (en) * 1996-12-20 2000-06-01 Novo Nordisk As Meiosis regulating compounds
BR9808803A (pt) * 1997-05-16 2000-07-18 Akzo Nobel Nv Derivado de 20-aralquil-5alfa-pregnano, uso do mesmo, e, composição farmacêutica
KR20010013401A (ko) 1997-06-04 2001-02-26 에프.지.엠. 헤르만스 감수분열 조절용 17β-알릴옥시(티오)알킬-안드로스탄유도체
ATE220686T1 (de) 1997-12-18 2002-08-15 Akzo Nobel Nv 17beta-aryl(arylmethyl)oxy(thio)alkyl- androstanderivative
IL139241A0 (en) 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
EP0957108A1 (en) * 1998-05-14 1999-11-17 Schering Aktiengesellschaft Unsaturated cholestane derivatives, pharmaceutical compositions comprising them and use of these derivatives for the preparation of meiosis regulating medicaments
CA2333320A1 (en) * 1998-05-26 1999-12-02 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
EP1087988A1 (en) * 1998-06-19 2001-04-04 Novo Nordisk A/S Meiosis regulating compounds
AU759344B2 (en) * 1998-12-11 2003-04-10 Akzo Nobel N.V. 22S-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity
IL143735A0 (en) * 1999-02-10 2002-04-21 Schering Ag Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
AU2794000A (en) 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
WO2000050066A1 (en) 1999-02-24 2000-08-31 Novo Nordisk A/S Treatment of infertility
CZ20012671A3 (cs) * 1999-02-26 2002-01-16 Novo Nordisk A/S Způsob in vitro oplodnění s pouľitím kultivačního média obsahujícího sterol aktivující meiosu
EP1163258B1 (en) * 1999-03-09 2002-12-11 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
EP1177205A1 (en) * 1999-05-10 2002-02-06 Schering Aktiengesellschaft 14$g(b)-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS
ATE306942T1 (de) 1999-09-16 2005-11-15 Novo Nordisk As Zusammensetzung zur in-vitro befruchtung
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
EP1285058A2 (en) * 2000-05-18 2003-02-26 Schering Aktiengesellschaft Fertilization of aged oocytes
EP1216701A1 (en) * 2000-12-22 2002-06-26 Schering Aktiengesellschaft Process to increase the concentration of meiosis-activating sterols (MAS) in the cholesterol synthesis and the use of potent inhibitors in the process
EP1245572A1 (en) * 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
US20050020666A1 (en) * 2003-07-25 2005-01-27 Dabur Research Foundation Cardioprotective agents
PL2028937T5 (pl) * 2006-05-22 2018-12-31 Vanda Pharmaceuticals Inc. Leczenie za pomocą agonisty melatoniny

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols

Also Published As

Publication number Publication date
JPH11501806A (ja) 1999-02-16
AU717180B2 (en) 2000-03-16
PL322106A1 (en) 1998-01-05
CZ279797A3 (cs) 1998-01-14
MX9706565A (es) 1997-11-29
AU4784596A (en) 1996-09-23
US5830757A (en) 1998-11-03
CA2214126A1 (en) 1996-09-12
NO974089L (no) 1997-09-05
WO1996027658A1 (en) 1996-09-12
NO974089D0 (no) 1997-09-05
BR9607673A (pt) 1998-06-16
HUP9800731A2 (hu) 1998-07-28
EP0813595A1 (en) 1997-12-29
RU2188006C2 (ru) 2002-08-27
KR19980702624A (ko) 1998-08-05

Similar Documents

Publication Publication Date Title
HUP9800731A3 (en) Stimulation of meiosis
HUP9900454A3 (en) Meiosis regulating compounds and their use
GB9505491D0 (en) Therapeutic agents
GB9513118D0 (en) Therapeutic agents
GB9513117D0 (en) Therapeutic agents
GB9505492D0 (en) Therapeutic agents
GB9526560D0 (en) Use of 2-Amino-Heterocycles
IL111122A0 (en) Methods of stimulating phagocytosis
GB9507291D0 (en) Therapeutic agents
PL326695A1 (en) Derivatives of stimulating aminoacids
GB9507348D0 (en) Therapeutic agents
GB9500580D0 (en) Therapeutic agents
GB9501865D0 (en) Therapeutic agents
ZA96725B (en) Use of phenyclyclohexylcarboxamides
HUP9802589A3 (en) Bone stimulating factor
GB9515868D0 (en) Therapeutic method
PL326080A1 (en) Short forms of chemokin beta-8
GB9525918D0 (en) Structure of armrest-driven wheelchair
ZA968062B (en) Bone stimulating factor
ZA955213B (en) Regulation of meiosis
GB9507224D0 (en) Therapeutic agents
GB9503377D0 (en) Therapeutic agents
GB9503332D0 (en) Implantable structures
CA76098S (en) Set of handbags
ZA962440B (en) Destressing of railtracks